CURRICULUM VITAE

CURRICULUM VITAE
(Fall, 2009)
Donald R. Bodner, M.D.
Professor of Urology
Case Western Reserve University
Cleveland, Ohio
Attending Physician
University Hospitals/ Case Medical Center
Staff Urologist
Cleveland VA Medical Center
Cleveland, Ohio
Email: [email protected]
Academic focus: neuro-urology, spinal cord medicine, stone disease
APPOINTMENTS
Interim Chair, Department of Urology, CWRU School of Medicine and UH Case Medical
Center, 5/1/07-7/31/09
Program Director: CWRU Urology Residency Program 5/1/07-7/31/08
Editor in Chief: Journal of Spinal Cord Medicine: 1/01/2006 to present
Urology Section Editor, Journal of Spinal Cord Medicine: 1992- 2006
Editorial Board: International Journal of Impotence Research, 2005-present
VA National Urology Field Advisory Committee, 2001-March 1, 2009
Chair 2004 –March 1, 2009.
VA National Surgery Advisory Board, Urology Chair, March 1, 2009 to present
Member: International Spinal Cord Injury Standards and Data Sets Committee, a joint
effort of the American Spinal Injury Association (ASIA) and the International Spinal Cord
Society (ISCoS) 2006- 2009
Reviewer: National VA Merit Review Committee, Rehabilitation Research and
Development, 2000 –present
Reviewer: Congressionally Directed Medical Research Programs (CDMRP), 2009
Panel Member: Paralyzed Veterans of America: The Consortium for Spinal Cord
Medicine 2003-2006
American Paraplegia Society: Board of Directors 2006-present; Program Committee
2006-2009
American Paraplegia Society
Netwellness: www.netwellness.org Urology Advisor
Consultant/Member Oncology Advisory Group to the Department of Veterans Affairs
Program Evaluation Oversight Committee – 2004-2008
CURRENT GRANTS
Electrical Activation of Afferent Nerves to Restore Bladder Function
Co-Investigator: Donald Bodner 5%
Department of Veterans Affairs
RR&D B3675R (PI Kenneth J. Gustafson) Production of micturition and continence via
peripheral afferent stimulation.
Type: Period: 4/1/06-3/31/09
Producing Micturition by combined afferent and efferent stimulation
Co-Investigator: Donald Bodner 5%
National Institute of Diabetes and Digestive and Kidney Disease R01 DK077089-01A1
(PI: Kenneth J. Gustafson, PhD)
Project Period: 09/01/2007-06/30/2011
Budget Period:: 9/1/2007-6/30/2008: $253,380
Selenium and Vitamin E Cancer Prevention Trial SELECT
Principal Investigator: Donald Bodner
Funding Agency: (SWOG)
Type: Period: 2001-present.
Study Site: Cleveland VA Medical Center
Botulinum Toxin A for management of spinal cord injury incontinence
Principal Investigator: Donald Bodner
Funding agency: Allergan
Type: Period: 2007-present.
Study Site: Cleveland VA Medical Center
Current Medical School Service:
Master Thesis Committee Advisor, Dr Hohete Case Western Reserve School of
Dentistry 7/1/07-6/30/08. “Periodontal Inflammation and Prostatitis -Is there an
association?
Master Thesis Committee Advisor: Josh Nishant, DDS: 7/1/08-6/30/09 “Relationship
between the Periodontal Inflammation and Elevated Prostate-Specific Antigen (PSA)
Levels in Patients with Prostatic Inflammation”
PERSONAL DATA
Date of Birth:
Office Address:
Office Phone:
Alternate Contact:
August 31, 1953
University Hospitals/ Case Medical Center
Department of Urology
11100 Euclid Avenue
Cleveland, Ohio 44106
(216) 844-5503
Dept. of Veterans Affairs Medical Center
Spinal Cord Injury Service 128W
10701 East Boulevard
Cleveland, Ohio 44106
Phone: (216) 791-3800, ext. 3062
MetroHealth Medical Center
Division of Urology
2500 MetroHealth Drive
Cleveland, Ohio 44109
EDUCATION
1975 - B.S.
Trinity College
Hartford, Connecticut
1979 - M.D.
Indiana University School of Medicine
Indianapolis, Indiana
1979 – 1980
Intern, Surgery
Case Western Reserve University
Cleveland, Ohio
1980 – 1981
Resident, Surgery
Case Western Reserve University
Cleveland, Ohio
1981 - 1983
Resident, Urology
Case Western Reserve University
Cleveland, Ohio
1983 – 1984
Chief Resident, Urology
Case Western Reserve University
Cleveland, Ohio
LICENSURE
FLEX
May 1979
Indiana #29413
August 14, 1979
Ohio #044291
November 20, 1979
SPECIALTY CERTIFICATION
Board Certified; The American Board of Urology, 1986; Recertified; 1994, 2004
Fellow, American College of Surgeons, 1987
MEDICAL SCHOOL AFFILIATION
7-1-84 to 12-31-84
Senior Instructor, Division of Urology
Department of Surgery,
Case Western Reserve University School of Medicine
1-1-85 to 6-30-92
Assistant Professor, Division of Urology
Department of Surgery,
Case Western Reserve University School of Medicine
7-1-92 to 6-30-99
Associate Professor, Dept. of Urology,
Case Western Reserve University School of Medicine
7-1-99 to present
Professor of Urology, Dept. of Urology
Case Western Reserve University School of Medicine
5-1-07 to 7/31/09
Professor and Interim Chair, Department of Urology,
UH Case Medical Center and Case Western Reserve
University School of Medicine
PROFESSIONAL ORGANIZATIONS:
American Spinal Injury Association (ASIA)
Urology Committee 1993-1995; 1995-1997, 1998- 2000
International Spinal Cord Society (ISCOS, Formerly International Medical Society of
Paraplegia)
North Central Section, American Urological Association
American Urologic Association
Society of University Urologists
Executive Committee VA Liaison, 2000-2005
Executive Committee Member-Councilman, 2000-2005
Subcommittee on Urology in the V.A. (1995-1998)
Nominating Committee 2003-2004
American Paraplegia Society
Board of Directors, 1988-1996, 2006- (ex-officio because of Editor of
Journal of Spinal Cord Medicine)
Nominating Committee Member - 1989-90; 1993-1996
Chairman - 1991-1992; 1995-1996; 1996-1997
Education Committee, 1993-1995
Long Range Planning Committee, 1995-2004
Secretary, Treasurer, 1989-1991
Vice President, 1991-1993
President, 1993-1995
Past President, 1995-1997
Program Committee 2002-2006, reappointed 2006-2009
Cleveland Urological Society
Secretary, Treasurer - 1990-1992
President - 1992-1993
Society for Urodynamics and Female Urology
International Continence Society
Societe Internationale D'Urologie
Cleveland Academy of Medicine
Ohio State Medical Association
PREVIOUS RESEARCH GRANTS
Consultant: “Career Training in Bladder Control Neural Prothesis” 2001-2004
NIH Grant No. HD40298-02
Effect of Sildenafil (Viagra) in Spinal Cord Injured Men.
Co-Principal Investigator: Donald Bodner
Agency: Pfizer.
Type: Period: 1998 – 2002; $75,000
Co-Principal Investigator: “Electrical Control of Bowel and Bladder in Spinal Cord Injury
Patients” VA Central Office, Rehab, Research and Development Service
Grant NO. B804-2R
1998-1999
$300,000
1999-2000
$241,000
2000-2001
$200,200
Co-Principal Investigator: “Neuroprosthetic Control of Bladder and Bowel in Spinal Injury
Patients” VA Central Office, Rehab. Research and Development Service
Grant NO. B804-RC
1994-1995
$193,700
1995-1996
$141,100
1996-1997
$120,200
Co-Investigator: “Bowel and Bladder Control Using Neuroprosthetic Devices”
HD/NR-93-05
1993-1995
$178,000
Co-Principal Investigator: “Neuroprosthetic Control of Bladder and Bowel in Spinal Injury
Patients” VA Central Office, Rehab. Research and Development Service
Pilot Grant NO. B91-299 PA
10-92 to 10-93
$ 50,000
Co-Investigator: “A Micturition Assist Device”
NIH - NINCDS Grant NO. NS22631-02
1987-1988
$ 78,297
1988-1989
$ 62,233
1989-1990
$ 72,970
1990-1992
$ 98,510
INDUSTRY FUNDED STUDIES
1.
A double-bind, placebo-controlled, multi-center study to determine the safety and
efficacy of Didronel in the treatment of painful bone metastasis from hormone resistant
prostate cancer, NORWICH EATON PHARMACEUTICALS INC., 1986.
(Co-Investigator).
2.
Multi-center comparison of Zoladex Depot and Surgical Castration in Metastatic Prostate
Carcinoma, STUART PHARMACEUTICALS, 1985-1988. (Co-Investigator).
3.
A multi-center comparison of Zoladex Depot and DES for patients with metastatic
prostate cancer who have refused orchiectomy, STUART PHARMACEUTICALS, 19851988.
(Co-Investigator).
4.
A double-bind comparative, safety, tolerance and efficacy study of parenteral Piperacillin
- Tazobactam (CL 298, 741) versus Ceftazidime for the treatment of hospitalized
patients with complicated UTIs. Phase III Multi-center Study. American Cyanamid Co.,
1988-1990.
(Co-Investigator).
5.
A study of Cefepime in the treatment of serious bacterial infections particularly those
caused by staphylococci, pseudomonas and other less common GRAM-NEGATIVE
BACILLI. Bristol-Myers Company, 1990-1991. (Co-Investigator).
6.
A phase II dose finding placebo controlled study of four dose levels of YM 617 in
patients with the signs and symptoms of benign prostatic hyperplasia. Yamanouchi
Pharmaceutical Company, Ltd., 1990. (Principal Investigator).
7.
A double-bind, placebo controlled, multi-center study to investigate the safety,
tolerability, and efficacy of MK-906 in patients with benign prostatic hyperplasia.
MERCK, SHARP & DOHME, 1988. (Co-Investigator).
8.
A double-bind, placebo-controlled, multi-center study to investigate the safety, tolerability
and efficacy of MK-906 in patients with benign prostatic hyperplasia, MERCK SHARP &
DOHME, 1989-1990. (Co-Investigator).
9.
A double-bind, placebo-controlled, multi-center extension study to investigate the safety,
tolerability and efficacy of MK-906 in patients with benign prostatic hyperplasia, 19891990. (Co-Investigator).
10.
An open extension to the multi-center, double-bind extension study to investigate the
safety, tolerability, and efficacy of MK-906 in patients with benign prostatic hyperplasia.
MERCK, SHARP & DOHME, 1989-1991. (Co-Investigator).
11.
Ultrasound Prostate Cancer Network, characteristics of adenocarcinoma and accuracy
of ultrasound compared to digital rectal exam in staging, 1989. (Co-Investigator).
12.
Ultrasound Prostate Cancer Network, transrectal ultrasound of prostate prior to
transurethral resection of prostate for benign prostatic hyperplasia, 1989. (CoInvestigator).
INDUSTRY FUNDED STUDIES (continued)
13.
Ultrasound Prostate Cancer Network, transrectal prostate ultrasound prior to
cystoprostatectomy for treatment of cancer of the bladder, 1989. (Co-Investigator).
14.
A double-blind randomization Placebo Controlled Dose Ranging Study of Atamestane to
Evaluate the Efficacy, Safety and Endocrinological Effects in Patients with benign
prostatic hyperplasia. BERLEX LABORATORIES, 1991. (Co-Investigator).
15.
Extended (up to 18 months) double-blind evaluation of Atamestane and placebo study to
the long-term efficacy, safety and endocrinological effects in patients with benign
prostatic hyperplasia. BERLEX LABORATORIES, 1991. (Co-Investigator).
16.
Third open extension to the multi-center, double-blind extension study to investigate the
safety, tolerability, and efficacy of Finasteride in patients with benign prostatic
hyperplasia. MERCK SHARP & DOHME, 1991. (Co-Investigator).
17.
An open-label extension study using Doxazosin tablets for the treatment of benign
prostatic hyperplasia in Normotensive patients. PFIZER PHARMACEUTICALS, 1991.
(Co-Investigator).
18.
A fourteen-week, double-blind, placebo controlled dose response study using Doxazosin
tablets for the treatment of benign prostatic hyperplasia in normotensive patients.
PFIZER PHARMACEUTICALS, 1991. (Co-Investigator).
19.
The effect of fourteen days treatment with SK & F 105657 on prostatic and serum DHT
levels in patients with benign prostatic hyperplasia scheduled for transurethral resection
of the prostate. SMITH KLINE BEECHAM PHARMACEUTICALS, 1991. (CoInvestigator).
20.
Clinical trials of safety and effectiveness of the prostate treatment machine (PTM) for
transrectal thermal therapy of patients with benign prostatic hyperplasia. PRIMUS
TECHNOLOGIES INC., 1991. (Co-Investigator).
21.
Clinical trials of the safety and effectiveness of the prostate treatment machine (PTM) for
transrectal thermal therapy of patients with benign prostatic hyperplasia using
temperature sensoring. PRIMUS TECHNOLOGIES, INC., 1991. (Co-Investigator).
22.
Clinical trials of the safety and effectiveness of the prostate treatment machine (PTM) for
transrectal thermal therapy of patients with benign prostatic hyperplasia the control
group. PRIMUS TECHNOLOGIES, INC., 1991. (Co-Investigator).
23.
A monitored release of named patient basis study for Zoladex Depot in metastatic
prostate carcinoma. ICI PHARMACEUTICALS, 1991. (Co-Investigator).
24.
A randomized controlled comparison of Deslorelin to Leuprolide for the treatment of
stage D2 prostate cancer. ROBERTS PHARMACEUTICAL CORP., 1992. (Principal
Investigator).
INDUSTRY FUNDED STUDIES (continued)
25.
26.
A one-year, multi-center, double-blind comparison of the effects of once-daily dosing
with three dose levels of SK & F 105657 or placebo in the treatment of symptomatic
benign prostatic hyperplasia with six-month untreated follow-up. SMITH KLINE
BEECHAM PHARMACEUTICALS, 1992. (Principal Investigator).
Multi-center Efficacy and Tolerability Study Comparing Proscar (Finasteride) and
placebo in the Treatment of Symptomatic Benign Prostatic Hyperplasia, MERCK, 1993.
(Principal Investigator).
27.
A two-year, open-label, multi-center study of oral Episteride 80 mg. once daily in the
treatment of benign prostatic hyperplasia (SK&F 105657/052). SMITH KLINE
BEECHAM PHARMACEUTICALS, 1993 – 1996. (Principal Investigator).
28.
A Three Month, Double-Blind, Placebo-Controlled, Randomized, Multi-center Study of
the Effects and Safety of SB 21649-S In Patients with Symptomatic Benign Prostatic
Hyperplasia, Smith Kline Beecham, King of Prussia, PA, 1995. (Principal Investigator).
29.
A Four Year Open Label Multicenter Study of Oral Epristeride 80 mg Once Daily in the
Treatment of BPH, Smith Kline Beecham, King of Prussia, PA; January, 1996 to August,
1996. (Principal Investigator).
30.
A Pharmacology Based Efficacy. Trial of Intravesical Mytamycin C in Bladder Cancer
and Interactive Pharmacology Studies (05-94-29). Ohio State University, Columbus,
Ohio; September, 1994 to 1997. (Co-Investigator).
31.
Long-Term Safety Study for Alprostadil Sterile Powder (PGE, Alprostadil S. Po.) in
Patients with Erectile Dysfunction. Pharmacia and Upjohn, Inc., Kalamazoo, Michigan,
July 1992 to June 1994. (Co-Investigator).
32.
Treatment of Erectile Failure by Means of a Medicated Urethral System for Erection
(MUSE). Vivus Company, Menlo Park, California, June 1993 to July 1995. (CoInvestigator).
33.
One-Year, Open-Label Evaluation of the Safety and Efficacy of Alprostadil Administered
by MUSE. Vivus Company, Menlo Park, California, June 1994 to July 1995. (CoInvestigator).
34.
A Placebo-Controlled Safety and Efficacy Study of Alprostadil Alphadex (PGE,-AlphaCyclodextrin) in the Treatment of Erectile Dysfunction followed by 48 weeks of OpenLabel Treatment. Corning Besselaar, Nashville, Tennessee, January 1993 to February
1996. (Co-Investigator).
35.
An Open-Label Study of Intracavernous Injections of Alprostadil Aphadex for use in the
Diagnosis of Erectile Dysfunction by Doppler Ultrasound. Schuarz Pharma, Milwaukee,
Wisconsin, November 1994 to July 1995. (Co-Investigator).
INDUSTRY FUNDED STUDIES (continued)
36.
A Multicenter Phase 111B Open Label Study of Intracavernous Injections of Alprostadil
Alphadex in the Treatment of Erectile Dysfunction in Patients with Insulin Dependent
Diabetes Mellitus, Schuarz Pharma-CioClin, Austin, Texas, March 1996 to January
1998. (Co-Investigator).
37.
A Treatment IND Protocol for the Compassionate Use of Elmiron for Patients with
Recurring Symptoms of Interstitial Cystitis. Baker, Norton Pharmaceuticals, Inc.,
Miami, Florida; March, 1994 to 1997. (Principal Investigator).
38.
A Randomized Double-Blind study with open label treatment extension to evaluate the
efficacy and safety of Viagra (sildenafil) in men with symptoms of depression and
erectile dysfunction PPD Pharmaco. Wilmington, North Carolina, September 1997 to
November 1998. (Co-Investigator)
39.
Two year open extension to a Double- Blind Randomized Placebo controlled multicenter study to investigate the long term effects of finasteride (MK-906) in patients with
BPH. Merck. Princeton, New Jersey, January 1997 to November 1998. (CoInvestigator).
40.
Efficacy and safety of Alfuzosin once daily tablets at two dose levels (10mg and 15mg)
vs placebo in patients with symptomatic BPH: A Placebo - Controlled Double Blind
study conducted in 3 parallel groups for 3 months followed by a nine month open label
extension PPD Pharmaco. Wilmington, North Carolina. Jan 1998 to 2002 (CoInvestigator).
41.
A Phase III Efficacy and Safety Study of Four Fixed Doses of Apomophoine SL Tablets
vs Placebo in the Treatment of Male Erectile Dysfunction IBRD - TAP Pharmaceuticals
Irvine, California August 1997 to August 1998. (Co-Investigator).
42.
A Double-Blind Randomized, Placebo-Controlled Two Center Three Way Crossover
Safety and Efficacy Study of Paroxetine Hydrochloride Capsules for the Treatment of
Premature Ejaculation. Pentech Pharmaceuticals, Wheeling Illinois, May 1997 to
January 1999. (Co-Investigator).
43.
A Multicenter Open-Label Dose Escalation Study of the Safety and Therapeutic Effects
of PPi-149 Depot Administration as an Intramuscular IM or Subcutaneous SC Injection in
Prostate Cancer Patients who are Candidates for Initial Hormonal Therapy. Praecis
Pharmaceuticals. Manisville, North Carolina. October 1997 to present. (Co-Investigator).
44.
A phase III Long-Term, Open-Label, Flexible Dose Efficacy and Safety Study of
Apomorphine SL Tab in the Treatment of Male Erectile Dysfunction IBRD - Tap
Pharmaceuticals . Irvine, California. January 1998 to present. (Co-Investigator).
45.
Dose Escalation Study with Tolterodine in Patients with Overactive Bladder. A single
Blind Study in Patients with Symptoms of Overactive Bladder including Urinary Urgency
and Frequency with or without Urge Incontinence. Pharmacia & UpJohn. Kalamazoo,
Michigan. December, 1997 to August 1998. (Principle Investigator).
INDUSTRY FUNDED STUDIES (continued)
46.
A Pilot Evaluation of the Safety and Efficacy Dose response of Topical Gel Formulation
of Prostaglandin El for the Treatment of Male Erectile Dysfunction. MacroChem.
Lexington, Mass. March 1998 to November 1998. (Co-Investigator).
47.
A phase III multicenter open label randomized study of abareliy depot vs. Lupron Depo
plus Cabodex in patients with prostate cancer who are candidates for initial hormone
therapy. Praecis. Cambridge, MA. Sept 1998 - present. (Sub-Investigator).
48.
Clinical investigation of high intensity focused ultrasound (HIFU) for the treatment of
Benign Prostatic Hyperplasia, (BPH). Focus Surgery. Indianapolis, IN. February 1999
– 2001. (Sub-Investigator).
49.
Effect of Sildenafil (Viagra) in Spinal Cord Injured Men. Pfizer. 1998 - 2002.
(Co-Investigator).
50.
Longterm follow-up Sildenafil (Viagra) Therapy in Erectile Dysfunction. Departmental.
April 2001 – Ongoing. (Co-Investigator).
51.
Questionnare Assessment of Erectile Function Treatment and Outcome. Departmental.
August 1998-Ongoing (Co-Investigator).
52.
Molecular Diagnosis of Erectile Dysfunction. Departmental. July 1998-Ongoing. (CoInvestigator).
53.
A Randomized, Double-Blind, Paralled Placebo Controlled Study of the Efficacy and
Safety of IC351 Administered “On-Demand” to Men Erectile Dysfunction. Bayer
Pharmaceuticals. December 2001-August 2002. (Co-Investigator).
54.
Platelet Cyclic GMP Levels as a Surrogate Marker for Penile Cyclic GMP Levels:
Platelets as a Surrogate Marker for Male Erectile Function. Departmental. December
2001-Ongoing. (Co-Investigator).
55.
Peyronie’s Disease Questionnaire for Men with Prostate Cancer. Departmental.
September 2001-Ongoing. (Co-Investigator)
56.
A Clinical Assessment of Patients Undergoing GYNECARE TVT with Abdominal Guides
for the Treatment of Stress Urinary Incontinence (Protocol 2001-012). GYCECARE.
February 2002-Ongoing. (Co-Investigator)
57.
Quality of Life Changes after Anti-Incontinence Surgery. Departmental. September
1991-Ongoing. (Co-Investigator)
58.
A Randomized, Double-Blinded Study Comparing Chondrogel (Autologous
Chondrocytes in Alginate Hydrogel for the Treatment of Women with Stress Urinary
Incontinence due to ISD. Curis. April 2000-Dec. 2001. (Co-Investigator)
INDUSTRY FUNDED STUDIES (continued)
59.
The Clinical Study of the Treatment of Organ Confined Prostate Cancer using the
Sonablate High Intensity Focus Ultrasound (Hufi). Focus Surgery. June 2001-Ongoing.
(Co-Investigator)
60.
Sexual Dysfunction in Men with Prostate Cancer who have undergone either Radiation
or have had Radical Surgery. Departmental. June 2000-Ongoing. (Co-Investigator)
61.
A Phase III Trial of Selenium for Prostate Cancer Prevention. Arizona Cancer Center.
August 2000-Ongoing. (Principal Investigator)
62.
Erectile Dysfunction Questionnaire on Men with Renal Disease. Departmental. March
2000-Ongoing. (Co-Investigator)
63.
Predicting Fertility after Varicocelectomy. Departmental. November 2001-Ongoing. (CoInvestigator)
64.
Does Chronic Sildenafile Use Improve Non-Sildenafil Erections. Pfizer. December
1999-Ongoing. (Co-Investigator)
65.
A Randomized Double-Blind, Parallel Group, Placebo-Controlled Investigation
Evaluating the Efficacy and Safety of Vardenafil Administered for 12 weeks in a FlexibleDose Regimen Compared to Placebo in Patients with Male Erectile Dysfunction Solely
Secondary to Traumatic Spinal Cord Injury. 2002-2005. (Principal Investigator)
66.
Prospective, Observational Registry and Patient Survey of the Management of Men with
Symptomatic Benign Prostatic Hyperplasia (BPH), SANOFI AVENTIS, 2004-2007.
(Principal Investigator)
67.
A Prospective, Open-Label, Study To Assess The Efficacy Of Alfuzosin 10 MG Tablet
Once A Day In Male Subjects Suffering From benign Prostate Hypertrophy Associated
With Lower Urinary Tract Symptoms And Erectile Dysfunction, SANOFI AVENTIS, 20052008 (Co-Investigator)
68.
A Prospective, Double-Blind Study to Determine the Safety and Efficacy of Botulinum
Toxin A for the treatment of Neurogenic Urinary Incontinence (Principal Investigator-Site:
VA)
AWARDS
1.
Certificate of Appreciation
Paralyzed Veterans of America
September 26, 1986
2.
American Paraplegia Society Selected Paper
Autoinjection for Erection
March, 1987
3.
Best Urology Paper of APIS Meeting
Prize included funding for presentation at 18th Annual Meeting American Spinal Injury
Association. March 19 - 22, 1987, Boston, Mass.
4.
Second runner-up, Travelling Fellowship Essay Contest, 62nd Annual Meeting, North
Central Section, American Urological Association Meeting,Orlando, Florida, November
13-19, 1988 "Urologic Changes After Spinal Cord Compression in Dogs".
5.
Russell Hibbs Award for the most outstanding Basic Science Research Paper presented
at the European Spinal Deformity Society and Scoliosis Research Society Meeting in
Amsterdam, Holland, September 22, 1989: "UROLOGIC FUNCTION FOLLOWING
EXPERIMENTAL CAUDA EQUINA COMPRESSION: CYSTOMETROGRAMS vs.
CORTICAL EVOKED POTENTIALS."
6.
First Place Ribbon for Best Urology Poster: Intraurethral MUSE for Treatment of Erectile
Dysfunction in SCI Patients; 24th Annual Meeting American Spinal Injury Association,
April 20 - 22, 1998, Cleveland, Ohio
7.
2007 Recipient- A. Eston Comarr, MD, Memorial Award for Clinical Service, American
Paraplegia Society, “given to an APS member who has demonstrated exceptional
accomplishments in the area of clinical care of persons with spinal cord injury, has had a
significant impact on the field of spinal cord medicine and is recognized as a leading
authority in the field of spinal cord health care and education.”
NATIONAL, HOSPITAL AND MEDICAL SCHOOL COMMITTEES
1.
Infection Control
Cleveland Veterans Administration Medical Center, 1986-1992
2.
Institutional Review Board Cleveland Veterans Administration Medical Center, 19881998
3.
Credentialing Committee for Department of Surgery University Hospitals of Cleveland,
1987-1992, *Chairman, Credentialing Committee, 1990-1992
4.
Credentialing Committee for Department of Urology , University Hospitals of Cleveland
Chairman, 1992-1994, 2005-2006
5.
NIDRR National Rehabilitation Engineering Center
for Functional Electrical Stimulation (FES-REC), 1988-Present
6.
Equipment Committee
University Hospitals of Cleveland, 1989
7.
Medical Director, Hospital Based Home Care,
Spinal Cord Injury Service
Cleveland Veterans Administration Medical Center, 1989-1998
8.
Coordination of basic science lectures, pathology lectures,
and Journal Club for urology residency - Division of Urology
CWRU School of Medicine, 1985-1996
9.
Institutional Review Board for Human Investigator
Department of Urology (University Hospitals), 1992-2009
10.
Medical Advisory Committee for the selection of the Patient Care Operations Support
System, University Hospitals of Cleveland, 1992-1995
11.
Faculty Council, Case Western Reserve University
School of Medicine
1995-1999
Steering Committee 1996-1999
Chair Elect
1996-1997
Chair
1997-1998
Past Chair
1998-1999
12.
Faculty Senate, Case Western Reserve University
School of Medicine
2001-2004
Budget Committee
2002-2003
GUEST EDITORSHIPS
Urologic Clinics of North America, Guest Editor, Spinal Cord Injury Edition, August, 1993.
JOURNAL REVIEWER
Journal of Spinal Cord Medicine (formerly Journal of American Paraplegia Society)
Editor-in Chief (1/2006 to present)
Journal of Urology
Spinal Cord (formerly named Paraplegia)
European Urology
International Journal of Impotence Research
Editorial Board (2005-present)
Journal Rehabilitation Research Development
GRANT REVIEWER
Spinal Cord Research Foundation (SCRF)
American Paraplegia Society
NIDRR Study Section, 2001
VA Merit Review Rehab Research and Development 2000 - present
PANEL MEMBER
Guidelines for Primary Medical Management of Urinary Obstruction from Benign Prostatic
Hyperplasia to the Dept. Of Veteran Affairs (finalizing guidelines and performance measures
1996-1999).
Topic Expert to provide clinical/technical review of the clinical practice on MS bladder
dysfunction for the Multiple Sclerosis Council and the Bladder Management guideline
development panel (1998).
Guidelines for Primary Care Management of Urinary Incontinence to Department of Veteran
Affairs (2002-2003).
Consortium of Spinal Cord Injury Guideline Panel. Clinical Practice Guideline for Bladder
Management in the SCI Adult for Health Care Professionals, 2003-2006 (published 2006).
PRESENTATIONS
1.
56th Annual Meeting, North Central Section, American Urological Association, Palliative
Nephrostomy for Relief of Ureteral Obstruction Secondary to Pelvic Malignancy, Marco
Island, Florida, October 17-23, 1982.
2.
Annual Resident Presentations, Urologic Complications in Pregnancy, Cleveland
Urologic Association, May, 1984.
3.
58th Annual Meeting, North Central Section, American Urological Association, Infundibular
Stenosis, Cedar Rapids, Iowa, September 19-22, 1984
4.
58th Annual Meeting, North Central Section, American Urological Association, Primary
Transitional Cell Carcinoma of the Prostate, Cedar Rapids, Iowa, September 19-22,
1984.
5.
Case Western Reserve University School of Medicine, Postgraduate Medical Education
Seminar, Entitled "Urology for the Non-urologist", Prostatitis and Urethritis, Cleveland,
Ohio, October 27, 1984.
6.
80th Annual Meeting, American Urological Association, Infundibular stenosis, Atlanta,
Georgia, May 12-16, 1985.
7.
31st Annual Meeting, American Paraplegia Society, Long-term Outcome of Ileal Loops in
Spinal Cord Injured Patients, Las Vegas, Nevada, September 4-6, 1985.
8.
59th Annual Meeting, North Central Section, American Urological Association, Urologic
Management of the Quadriplegic Female, Palm Beach, Florida, November 3-9, 1985.
9.
59th Annual Meeting, North Central Section, American Urological Association, LongTerm Outcome of Ileal Conduit in Spinal Cord Injured Patients, Palm Beach, Florida,
November 3-9, 1985.
10.
59th Annual Meeting, North Central Section, American Urological Association, Ruptured
Penis, Palm Beach, Florida, November 3-9, 1985.
11.
Case Western Reserve University School of Medicine, "Urology for the Non-urologist",
Benign Prostatic Hyperplasia, Cleveland, Ohio, November 23, 1985.
12.
Case Western Reserve University School of Medicine, Postgraduate Course Entitled:
"Impotency": a) Course Director; b) Talk Entitled: "Self-Injection for Impotence", An
update (April 19, 1986).
13.
81st Annual Meeting, American Urological Association, AMS Sponsored Round Table
Discussion. "Papaverine and Impotence". Invited Faculty: Bodner, Virag, Fishman,
Furlow, Goldstein, Waggner, Sidi, New York, New York, May 19-23, 1986,
14.
32nd Annual Meeting, American Paraplegia Society, Autoinjection for Erection in the
Spinal Cord Injured Male, Las Vegas, Nevada, September 3-5, 1986.
PRESENTATIONS (continued)
15.
Case Western Reserve University School of Medicine, Postgraduate Course Entitled:
"Urology for the Non-urologist", October 25, 1986, 1) Prostatitis and Urethritis; 2)
Impotency.
16.
60th Annual Meeting, North Central Section, American Urological Association, Injection
of Vasoactive Medications in the Spinal Cord Injured Male, Palm Springs, California,
November 9-16, 1986.
17.
60th Annual Meeting, North Central Section, American Urological Association, Fine
Needle Aspiration Biopsy of the Prostate in Detecting Cancer, Palm Springs, California,
November 9-16, 1986.
18.
60th Annual Meeting, North Central Section, American Urological Association, Ligation of
the Bladder Neck as Alternative to Supravesical Diversion, Palm Springs, California,
November 9-16, 1986.
19.
18th Annual Meeting, American Spinal Injury Association, (American Paraplegia Society
Selected Paper) Autoinjection in Spinal Cord Injured Male, Boston, MA, March 19-22,
1987.
20.
Case Western Reserve University School of Medicine, Postgraduate Course Entitled:
Update in Urologic Oncology, Diagnosis and Management of Localized Renal Cell
Carcinoma, April 24, 1987.
21.
Annual Meeting of International Medical Society of Paraplegia, Role of Vasoactive
Medication in SCI Potency, Aylesbury, England, May 13-15, 1987.
22.
61st Annual Meeting, North Central Section, American Urological Association,
Adenocarcinoma in the Residual Bladder after urinary diversion for neurogenic bladder,
Detroit, Michigan, September 16-19, 1987.
23.
61st Annual Meeting, North Central Section, American Urological Association, Erythema
Gangrenosum, Detroit, Michigan, September 16-19, 1987.
24.
61st Annual Meeting, North Central Section, American Urological Association,
DISCUSSANT/REVIEWER, Prostate, Detroit, Michigan, September 16-19, 1987.
25.
33rd Annual Meeting, American Paraplegia Society, E.S.W.L. in Quadriplegics - Can It
Safely Be Performed Under Local Anesthesia? Las Vegas, Nevada, September 20-23,
1987.
26.
Visiting Professor, Norwich Eaton Pharmaceuticals, Urinary Tract Infections, Norwich,
New York, October 1-2, 1987.
27.
Urology for the Non-urologist Postgraduate Course, Urethral Discharge, October 31,
1987.
PRESENTATIONS (continued)
28.
Urology for the Non-urologist Postgraduate Course, Initial Management of the Infertile
Male, October 31, 1987.
29.
Cuyahoga Community College lecture for Physician Assistant Students, Urinary Tract
Infections, Cuyahoga Community College, Cleveland, February 8, 1988.
30.
Case Western Reserve University School of Medicine, 2nd year class lecture, GU
neoplasms, February 11, 1988.
31.
Case Western Reserve University School of Medicine, Surgery Grand Rounds: Ureteral
Injuries, February 13, 1988.
32.
Geriatric City-Wide Grand Rounds: Urinary Incontinence in the Elderly, Cleveland
Veterans Administration Medical Center, March 4, 1988.
33.
Advances in the Management of Spinal Cord Injury, Case Western Reserve University
School of Medicine Postgraduate Symposium. Treatment of Bladder-Sphincter
Dyssynergia, March 18, 1988.
34.
Advances in the Management of Spinal Cord Injury, Case Western Reserve University
School of Medicine Postgraduate Symposium. Options for Impotence and Fertility in the
SCI Male, Cleveland, Ohio, March 19,1988.
35.
Advances in the Management of Spinal Cord Injury, Case Western Reserve University
School of Medicine Postgraduate Symposium. Moderator for Urologic Section: Recent
Advances in the Management of Urinary Stones in the SCI Patient and Autonomic
Dysflexia - A New Look At An Old Problem, Cleveland, Ohio, March 19, 1988.
36.
Visiting Professor, Norwich Eaton Pharmaceuticals, Antibiotic Usage in Urology,
Norwich, New York, April 19-20, 1988.
37.
Quest for Excellence in Spinal Cord Care and Practice, Case Western Reserve
University School of Medicine Postgraduate Course, Management of Urologic Problems
of the SCI Patient, Cleveland, Ohio, May 2, 1988, Cleveland.
38.
Quest for Excellence in Spinal Cord Care and Practice, Case Western Reserve
University School of Medicine Postgraduate Course, Sexual Options for SCI males, May
3, 1988.
39.
Annual Meeting of International Medicine Society of Paraplegia, The Use of Verapamil in
the Treatment of Detrusor Hyperreflexia, Perth, Western Australia, May 10-12, 1988.
40.
Rehabilitative Medical Service Grand Rounds, "URINARY INCONTINENCE", VAMC,
Cleveland, Ohio, June 27, 1988.
41.
34th Annual Meeting, American Paraplegia Society, Pharmacotherapy in Detrusor
Hyperreflexia, Las Vegas, Nevada, September 6-9, 1988,
PRESENTATIONS (continued)
42.
34th Annual Meeting, American Paraplegia Society, Poster: Psychosocial and Sexual
Impact of SCI on the Male, Las Vegas, Nevada, September 6-9, 1988.
43.
62nd Annual Meeting, North Central Section, American Urological Association, The Effect
of Verapamil on Detrusor Hyperreflexia, Orlando, Florida, November 13-19, 1988.
44.
62nd Annual Meeting, North Central Section, American Urological Association, Poster:
Urologic Changes After Spinal Cord Compression in Dogs, Orlando, Florida, November
13-19, 1988.
45.
35th Annual Meeting, American Paraplegia Society, The Use of Verapamil in the
Treatment of Autonomic Dysflexia, Las Vegas, Nevada, April 5-9, 1989.
46.
35th Annual Meeting, American Paraplegia Society, Moderator: Investigation Section.
SCI Research, Las Vegas, Nevada, April 5-9, 1989. .
47.
Annual Meeting of the International Medical Society of Paraplegia, Poster: The Use of
Ultrasound in the Urological Management of the Spinal Cord Injured Patient, Rome,
Italy, May 4-6, 1989.
48.
84th Annual Meeting, American Urological Association, The Use of Office ultrasound in
the Spinal Cord Injured, Dallas, Texas, May 7-11, 1989.
49.
CWRU School of Medicine Postgraduate. Course Entitled: "Female Urology" Talk
Entitled: "Pharmacologic Management", Cleveland, Ohio, June 3, 1989.
50.
Urinary Incontinence in the Elderly - Symposium sponsored by University Center on
Aging and Health, CWRU School of Medicine; Evaluation and Assessment of
Incontinence in the Elderly, Cleveland, Ohio, June 9, 1989.
51.
Invited Speaker: American Association of Physically Handicapped: Sexual Options for
the Disabled, Cleveland, Ohio, August 15, 1989.
52.
63rd Annual Meeting, North Central Section, American Urological Association, Urologist
Performed Ultrasound in the Routine Follow-up of the SCI Patient, Chicaco, Illinois,
September 20-23, 1989.
53.
Spinal Cord Injury Symposium, (PVA, MARMEC, and Dayton VAMC), Dayton, Ohio:
Sexual Functions and Dysfunctions: Options, October 23-24, 1989.
54.
Medical Grand Rounds - Hough Norwood Clinic, Understanding urinary
incontinence in the elderly, Cleveland, Ohio, November 8, 1989.
55.
Visiting Professor, Department of Urology, Kyoto Prefectural University School of
Medicine, Lecture: New Concepts in Urologic Management of Spinal Cord Injured
Patients, Kyoto, Japan, March 2-6, 1990.
PRESENTATIONS (continued)
56.
85th Annual Meeting, American Urological Association, Vasoconstrictive Devices vs.
Injection Therapy: A Prospective Study for SCI patients, New Orleans, LA, May 13-17,
1990.
57.
Annual Meeting of the International Medical Society of Paraplegia, The Role of
Intracorporal Injection of Vasoactive Medications For Restoration of Erection in the SCI
Male – A Three-Year Follow-up, Ramat Gan, Israel, June 4-7, 1990.
58.
CWRU Postgraduate Education - Surgery Today: Impotence, Cleveland, Ohio, June 13,
1990.
59.
CWRU Department of Surgery - Resident Reunion: Surgery for Impotence, Cleveland,
Ohio, June 15, 1990.
60.
36th Annual Meeting, American Paraplegia Society, Moderator: Urologic Surgery, Las
Vegas, Nevada, September 4-6, 1990.
61.
CWRU School of Medicine, Postgraduate Course: Management of BPH and Prostatic
Cancer. Lecture: Transurethral Resection of the Prostate. Cleveland, October 20,
1990.
62.
CWRU School of Medicine, Postgraduate Course: Management of BPH and Prostatic
Cancer. Lecture: Patient Assessment and Urodynamic Findings. Cleveland, October
20, 1990.
63.
40th Annual Meeting of the National Kidney Foundation, Inc., Invited Speaker:
Impotency and Infertility in End Stage Renal Disease (Council on Urology Symposium):
Non-Surgical Management of the Impotent Male, Washington, D.C., November 28 December 2, 1990.
64.
Rehabilitative Grand Rounds MetroHealth Medical Center, Importance of Urologic
Management after Spinal Cord Injury, Cleveland, Ohio, April 19, 1991.
65.
New Concepts in Impotence. Lorain, Ohio, April 27, 1991.
66.
CWRU Postgraduate Education: Surgery Today: New Concepts in Infertility, Cleveland,
Ohio, May 1, 1991.
67.
Annual Meeting of International Medical Society of Paraplegia, The Effect of Patient
Compliance on Long-term Urologic Outcome of Spinal Cord Injury, Aylesburg, England,
May 15-17, 1991.
68.
CWRU Postgraduate Education: Director Urology Workshop. Update Clinical Skills,
Course Director. Lecture: Incontinence - Evaluation and Management, Cleveland, Ohio,
June 20-21, 1991.
PRESENTATIONS (continued)
69.
37th Annual Meeting, American Paraplegia Society, Urologic Complications and Bladder
Pressure in Patients with Spinal Cord Injury, Las Vegas, September 3-5, 1991.
70.
65th Annual Meeting, North Central Section American Urological Association, The Effect
of Patient Compliance in Urologic Outcome in Spinal Cord Injury Patients, Scottsdale,
Arizona, November 3-9, 1991.
71.
65th Annual Meeting, North Central Section, American Urological Association, Long-term
Results with Injection Therapy in Erection in Patients with Spinal Cord Injury, Scottsdale,
Arizona, November 3-9, 1991.
72.
65th Annual Meeting, North Central Section, American Urological Association, Video
prostatectomy, Scottsdale, Arizona, November 3-9, 1991.
73.
CWRU Postgraduate Education: SURGERY TODAY: Neurogenic Bladder -- New
Approaches to Therapy, Cleveland, Ohio, December 11, 1991.
74.
North Central Section, American Urological Association. Continuing Education Program,
Pathophysiology of Incontinence, Cleveland, Ohio, September 24-27, 1992.
75.
66th Annual Meeting, North Central Section American Urological Association, Initial
Experience with Anterior Sacral Root Stimulation for Bladder Emptying in SCI patients,
Puerto Rico, October 25-31, 1992.
76.
Annual meeting of International Medical Society of Paraplegia, Long-term Urologic
Complications in SCI Patients, Ghent, Belgium, May 20, 1993.
77.
Nursing Urology Workshop (International Urological Services), Incontinence and
Interstitial Cystitis, Cleveland, Ohio, April 14-15, 1994.
78.
Case Western Reserve University School of Medicine Continuing Education. Prostate
Disease in the Elderly: An Update for Primary Care Physicians: Benign Prostatic
Hypertrophy. Cleveland, Ohio - May 25, 1994.
79.
Annual Meeting of International Medical Society of Paraplegia, TrimethoprimSulfamethoxazole prophylaxis against Urinary Tract Infection in the Chronic Spinal Cord
Injury Patient. Stone Disease in SCI Patients By Crystal Analysis, Kobe, Japan,
May 31 - June 2, 1994.
80.
Visiting Professor, Spinal Cord Injury Unit. Tampa Department of Veteran Affairs
Medical Center. Tampa, Florida - September 26-28, 1994.
81.
40th Annual Meeting American Paraplegia Society: Focus Session - Spinal Cord Injury
Urology - "Newer Treatments of Bladder-Sphincter Dyssynergia." Las Vegas, Nevada September 5-9, 1994.
82.
Medical Management of Benign Prostatic Hypertrophy - A look at the new alphablockers, CWRU Continuing Education. Cleveland, Ohio - June 21, 1995.
PRESENTATIONS (continued)
83.
Annual Meeting of International Medical Society of Paraplegia, Poster: Incidence and
Etiologic Factors for Stone Formation in Spinal Cord Injury Patients, Nov. 1 - Nov. 4,
1995, New Delhi, India.
84.
Annual Meeting of International Medical Society of Paraplegia, Invited APS State of Art
Lecture: Pathophysiology of Autonomic Dysreflexia, Atlanta, Georgia, Aug. 18 - Aug. 20,
1996.
85.
Annual Meeting North Central Section, American Urologic Association, Poster: United
States Experience with the Brindley Anterior Sacral Root Stimulator for Bladder
Management in Spinal Cord Injury Patients, Tucson, Arizona, Oct. 28 - Nov. 2, 1996.
86.
Annual Meeting, American Urologic Association, Poster: United States Experience with
the Brindley Anterior Sacral Root Stimulator for Bladder Management in Spinal Cord
Injury Patients, New Orleans, Louisiana, April 12 - April 17, 1997.
87.
Annual Meeting North Central Section, American Urologic Association, Poster: MUSE
for Treatment of Erectile Dysfunction in SCI Male. Presentation: Posterior Sacral
Rhizotomy for Treatment of Detrusor Hyperreflexia in SCI Patients, Monterey, California,
September 22-27. 1997.
88.
Evaluation and Management of Cancer for the Primary Practitioner - Prostate Cancer.
CWRU Spring 1998, CME Conference, Cleveland, Ohio, March 14, 1998.
89.
Symposium on functional electrical stimulation, (Pre Conference Symposium) 24th
Annual meeting, American Spinal lnjury Association, Cleveland, Ohio April 19, 1998,
Experience with Anterior Sacral Root Stimulation in SCI Patients.
90.
24th Annual Meeting, American Spinal Injury Association, 20 - 22, 1998 Instructional
Course “Urologic Mangements of Individuals with Spinal Cord injury” Poster:
Intraurethral alprostadil (MUSE) for treatment of erectile dysfuction in the SCI male,
Cleveland, Ohio, April 20-22, 1998.
91.
Moderator/Discussant: “EXPLORING OPPORTUNITIES TO RESTORE SEXUAL
FUNCTION BY ELECTRICAL ACTIVATION OF THE NERVOUS SYSTEM. CWRU
APPLIED NEURAL CONTROL RESEARCH DAY, Cleveland, Ohio, May 11 and 12,
1998.
92.
Annual Meeting International Medical Society of Paraplegia, Iguzu Falls, Brazil, The role
of Intraurethral Alprostadil for restoring erections in the SCI male, June 17-20, 1998.
93.
Initial United States Experience with the Bradley Anterior Sacral Root Stimulator.
Presented at The American Urological Association 93rd Annual Meeting. San Diego, CA,
May 30-June 4, 1998.
94.
Visiting Professor, Medical College of Ohio, June 2-3, 1999.
PRESENTATIONS (continued)
95.
Annual Meeting North Central Section AUA, Anterior Sacral Root Stimulation for
Management of the Neurogenic Bladder in Spinal Cord Injury Patients, Chicago, Illinois,
September 22-25, 1999.
96.
95th Annual Meeting AUA –Society for Urodynamics and Female Urology, Invited
Speaker: Review of Anterior Sacral Root Stimulation in Spinal Cord Injury Patients,
Atlanta, Georgia, April 28, 2000.
97.
96th Annual Meeting AUA- Plenary Session, Urinary Incontinence, Anaheim, CA,
June 2-7, 2000.
98.
48th Annual Meeting-American Paraplegia Society, Symposium Director: Longterm
Urologic Care of the Spinal Cord Injury/Disease Individual, Las Vegas, Nevada,
September 2-5, 2002.
99.
Annual Meeting North Central Section AUA, Surgical Access and Anatomy of the
Puderval Nerve, Chicago, Illinois, September 18-21, 2002.
100.
50th Annual Meeting-American Paraplegia Society, Symposium Director: Sexual
Function and Fertility in SCI, Las Vegas, Nevada, September 2004.
101.
51st Annual Meeting-American Paraplegia Society, Symposium Director: Update on
Multiple Sclerosis, Las Vegas, Nevada, September 2006.
102.
Invited Lecture: Pharmacology of the over active bladder. Annual Meeting North Central
Section AUA, San Diego California, September, 16-18, 2006.
103.
52nd Annual Meeting-American Paraplegia Society, Symposium Director: Reproductive
Technology and SCI an Update, Orlando, Florida, August, 2007.
BIBLIOGRAPHY
1.
Bodner DR, Lipuma JP and Resnick MI: Imagining Modalities: Basic principles and
utilization of ultrasound in urologic malignancies. Principles and management of
urologic cancer. Javadpour, N. (ed.), 2nd Edition, Williams & Wilkins Company.
Baltimore, MD, 1983.
2.
Bodner DR, Bryan PR, Lipuma JP and Resnick MI: Ultrasonograpy of the Urinary
Bladder in Ultrasound in Urology. Resnick, MI and Sanders, RD, (eds.), 2nd Edition.
Williams & Wilkins Company, Baltimore, MD, 1984.
3.
Bodner DR, Kursh ED and Resnick MI: Palliative nephrostomy for relief of ureteral
obstruction secondary to malignancy. Urology XXIV:8 (1984).
4.
Bodner DR, Kursh ED and Resnick MI: Palliative nephrostomy for relief of ureteral
obstruction secondary to malignancy. In: Yearbook of cancer. Yearbook Medical
Publishers, Chicago, IL, 1985.
5.
Bodner DR, Cohen JK and Resnick MI: Primary transitional cell carcinoma of the
prostate. Journal D'Urologie, 91, Number 3:157-158, 1985.
6.
Bodner DR: Impotence: Evaluation and treatment. In Spirnak JP (ed.): Primary Care.
Clin. N. Am., Vol. 12, No. 4, 1985, 719-33.
7.
Maksem JA, Suarez and Bodner DR: Fine needle aspiration biopsy of the prostate
gland. Cystopathology: Vol. 13, No.4, 1985, 2-6.
8.
Bodner DR, Lipuma JP and Resnick MI: Percutaneous drainage of the obstructed
kidney. In: Re-operative surgery of the abdomen. Fry, DE, Editor, Marcel Dekkor, New
York, 1986.
9.
Hampel N, Bodner DR and Persky L: Ileal and jejeunal loops. Urol. Clin. N.Am., 13
(No.2):207-224, 1986.
10.
Bodner DR, Cohen IK, Resnick MI: Primary Transitional Cell Carcinoma of the
Prostate. J Urology (Paris) 1986; 92(2):121-2.
11.
Bodner DR, Caldamone AA and Resnick MI: Acquired infundibular stenosis. Urology,
29: 19-21, 1987.
12.
Bodner DR, Schultz CL and Resnick MI: Imaging techniques of the adrenal gland. In:
Javadpour N. (ed.). Principles and management of adrenal cancer, London, SpringerVerlag, 1987, pp 69-82.
13.
Bodner DR: Impotence. In Resnick MI and Kursh ED (eds): Urology: Problems in
Primary Care. Medical Economics, Oradell, 1987, pp. 123-128.
14.
Bodner DR: Abscess in and about the kidney. In Resnick, MI and Kursh, ED
(eds.): Urology: Problems in primary care. Medical Economics, Oradell, 1987, pp. 113116.
BIBLIOGRAPHY (continued)
15.
Bodner DR: Urinary tract infections in men. In: Resnick MI and Kursh ED (eds.):
Urology: Problems in Primary Care. Medical Economics, Oradell, 1987, pp. 107-112.
16.
Bodner DR: Adrenal Tumors. In: Resnick MI and Kursh ED (Eds.): Urology: Problems
in Primary Care. Medical Economics, Oradell, 1987, pp. 205-210.
17.
Bodner DR: Male sexual dysfunction. In Resnick MI and Kursh, ED (eds.): Urology:
Problems in Primary Care. Medical Economics, Oradell, 1987, pp.117-122.
18.
Bodner DR: Urinary retention in the male. In: Resnick MI and Kursh ED (eds.):
Urology: Problems in Primary Care. Oradell, 1987, pp. 311-316.
19.
Bodner DR: Hydroceles in adults. In: Resnick MI and Kursh ED (eds.): Current
Therapy in Genitourinary Surgery, Toronto, 1987. B.C. Decker, Inc.
20.
Bodner DR, Hampel N, Maksem JA, Suarez M and Resnick MI: Aspiration biopsy of the
prostate. World J. Urol., 5:62-64, 1987.
21.
Bodner DR, Lindan R, Leffler E, Kursh ED and Resnick MI: The application of
intracavernous injection of vasoactive medications in the spinal cord injured male. J.
Urol., 138:310-311, 1987.
22.
Lindan R, Leffler E and Bodner DR: Urologic management of the quadriplegic female.
Paraplegia, Vol. 25 (5): 381-385, 1987.
23.
Althof SE, Turner LA, Levin SB, Risen C, Kursh ED, Bodner DR, and Resnick MI:
Intracavernosal injection in the treatment of impotence: A prospective study of sexual,
physiological and marital functioning. Journal of Sexual Marital Therapy. Vol. 3, No. 3
155-167, 1987.
24.
Bodner DR: Urologic management of the spinal cord injured patients. In: Resnick, MI
(ed.): Current Trends in Urology. Vol. 4, Williams and Wilkins, 1988, pp. 29-42.
25.
Spirnak JP, Bodner DR and Resnick MI: Extracorporal shock wave lithotripsy in
traumatic quadriplegic patients: Can it safely be performed without anesthesia? J. Urol.,
139:18, 1988.
26.
Bodner DR: Urethral Syndrome. Urol. Clin. N. Am. Vol. 15, No. 4:699-704, 1988.
27.
Kursh ED and Bodner DR: Alternative method to nerve sparing radial retropubic
prostatectomy. Urology, Vol. 32, No. 3:205-209, 1988.
28.
Bodner DR: Critical review of pharmacologic treatment of male infertility. Seminars in
Reproductive Endocrinology. Vol. 6, No. 4:377-384., 1988.
29.
Kursh ED, Bodner DR, Resnick MI, Althof, SE, Turner, L, Risen, C and Levine, S:
Injection therapy for impotence. Urol. Clin. N. Am. Vol. 15, No. 4:625-629, 1988.
BIBLIOGRAPHY (continued)
30.
31.
Mortimer JT, Sweeney JD, Bodner DR and Ferguson AS: (Abstract) An implantable cuff
electrode for collision block of pudendal nerve motor activity. Proc. 10th Annual Conf. of
the IEEE - EMBS, pp. 1523-1524, 1988. 15, No. 4:625-629, 1988.
Sweeney JD, Mortimer JT, Bodner DR and Ferguson AS: (Abstract) Collision Block of
Motor Activity in Peripheral Nerve. Proc. of the World Congress on Medical Physics and
Biomedical Engineering, Physics in Med. & Biol., Vol. 33, Suppl. 1, p. 162, 1988.
32.
Bodner DR, Lindan R, Leffler E and Resnick MI: The effect of verapamil on the
treatment of detrusor hyperreflexia, in the spinal cord injurd population. Paraplegia,
27:364-369, 1989.
33.
Levine SB, Althof SE, Turner LA, Risen CB, Bodner DR, Kursh ED and Resnick MI:
Side effects of self-administration of intracavernous papaverine and phentolamine for the
treatment of impotence. J. Urol., 141:54-57, 1989.
34.
Sweeney JD, Mortimer JT and Bodner DR: Acute Animal Studies on Electrically
Induced Collision Block of Pudenal Nerve Motor Activity. Neurourol. and Urodynamics,
8:521-536, 1989.
35.
Bodner DR: Sacral Root Electrical Stimulation of the Bladder. In: Resnick MI (ed.):
Problems in Urology: Evaluation and Use of the New Technology in Urologic Surgery.
Vol. 3, No. 3:386-394, 1989.
36.
Levine SB, Althof SE, Turner LA, Kursh ED, Bodner DR, Resnick MI and Risen CB:
Benefits and problems with intracavernosal injections for the treatment of impotence.
Medical Aspects of Human Sexuality, 23:38-40, 1989.
37.
Althof SE, Turner LA, Levine SB, Risen C, Kursh E, Bodner DR and Resnick MI: Why
do so many people drop out from auto-injection therapy for impotence? J. Sex Marital
Ther., 15:121, 1989.
38.
Turner LA, Althof SE, Leuse SB, Risen CB, Bodner DR, Dursh ED, Resnick MI: Selfinjection of Papaverine and Phenotolamine in Treatment of Psychogenic Impotence. J.
Sex Marital Ther. 15(3):163-7, 1989.
39.
Bodner DR, Witcher M and Resnick MI: Application of Office Ultrasound in the
management of the spinal cord injured patient. J. Urol., 143:969-972, 1990.
40.
Bodner DR and Resnick MI: Complications of surgery for removal of renal and ureteral
stone. In: Marshall, FF: Urological Complications, Medical and Surgical, Adult and
Pediatric, 2nd Edition, St. Louis, Mosby Year Book, 1990, pp. 182-199.
41.
Bodner DR: How Electrical Stimulation Improves Micturition. Contemporary Urology,
November, 1990, pp. 39-45.
42.
Turner LA, Althof SB, Levine SB, Tobias TR, Kursh ED, Bodner D and Resnick MI:
Treating Erectile Dysfunction with External Vacuum Devices: Impact upon Sexual,
Psychological and Marital Functioning. J. Urol., 144:79-82, 1990.
BIBLIOGRAPHY (continued)
43.
Sweeney JD, Mortimer JT and Bodner DR: Animal Study of Pudendal Nerve Cuff
Electrode Implants for Collision Block of Motor Activity. Neurology and Urodynamics,
9:83-93, 1990.
44.
Bodner DR, Delamater R, Bohlman H, Witcher M, Biro C and Resnick MI: Urologic
changes after cauda equina compression in dogs. J. Urol., 143:186-190, 1990.
45.
Bodner DR, Resnick MI: Complications of open renal stone surgery. In: Smith, RB and
Ehrlich, RM (eds.): Complications of Urologic Surgery: Prevention and Management.
Philadelphia, W.B. Saunders, 1990, pp. 160-172.
46.
Bodner DR: Cushing's syndrome. In: Resnick MI and Nieh PT (eds): Case Studies in
Urology for the House Officers. Baltimore, Williams and Wilkens, pp. 213-215, 1990.
47.
Bodner DR: Urinary retention. In: Resnick MI and Nieh PT (eds): Case studies in
urology for the house officers. Baltimore, Williams and Wilkens, pp. 173-175, 1990.
48.
Delamarter RB, Bohlman HH, Bodner D and Biro C: Urologic Function After
Experimental cauda Equina Compression. Cystometrograms Versus Cortical-Evoked
Potentials. Spine, Vol. 15, No. 9:864-870, 1990.
49.
Bodner DR, Resnick MI: Ultrasonograpy of the urinary bladder. In: Ultrasonography of
the Urinary Tract, third edition. MI Resnick, MD Rifkin (eds), Williams and Wilkins,
Baltimore, 1991, p 250.
50.
Turner LA, Althof SE, Levine SB, Risen CBB, Bodner DR, Kursh ED and Resnick MI:
Sexual, psychological and marital impact of self-injection of Papaverine and
Phentolamine: A long-term prospective study. J. Sex & Marital Therapy 17:101-112,
1991.
51.
Bodner DR and Resnick MI: Ultrasound of the Bladder. In: Resnick MI and Rifkin MD,
Ultrasonography of the Urinary Tract. Vol. 3., Baltimore, Williams & Wilkins, pp. 250281, 1991.
52.
Turner LA, Althof SB, Levine SB, Bodner DR, Kursh ED, Resnick MI: External Vacuum
Devics in the Treatment of Erectile Dysfunction: A one year study of Sexual and
Psychological mpact. J. Sex Martial Ther., 17(2): 81-93, 1991.
53.
Pretlow TG, Pretlow TP, Yang B, Kaetzel CS, Delmoro CM, Kamis SM, Bodner DR,
Kursh ED, Resnick MI and Bradley EL: Tissue concentrations of prostate specific
antigen in prostate carcinoma and benign prostatic hyperplasia. Int. J. Cancer:49, 645649, 1991.
54.
Bodner DR and Kursh ED: Vacuum constrictive devices. Current Opinion in Urol.
1(2):149, 1991.
BIBLIOGRAPHY (continued)
55.
Bodner DR: Endocrine Disorders and Impotence. In: Resnick MI and Kursh ED (eds):
Current therapy in Genitourinary Surgery. (2nd Edition), B.C. Decker. St. Louis, 1992,
pp. 545-546.
56.
Bodner DR: Spermatocele. In: Resnick MI and Kursh ED (eds): Current Therapy in
Genitourinary Surgery (2nd Edition), B.C. Decker, St. Louis, 1992, pp. 429-431.
57.
Bodner DR, Resnick MI: Operations for renal stones. In: Mastery of Surgery-Urologic
Surgery. JE Fowler, Jr., editor, Little Brown & Co., Boston, 1992, pp 52.
58.
Bodner DR: Priapism. In: Resnick MI and Kursh ED (eds): Current Therapy in
Genitourinary Surgery. B.C. Decker, St. Louis, pp. 429-431, 1992.
59.
Turner LA, Althof SE, Levine SB, Bodner DR, Kursh ED, and Resnick MI: A 12-month
comparison of the effectiveness of two treatments for erectile dysfunction: Self-injection
versus external vacuum devices. Urology, February, 1992, Volume 39(2):139-44.
60.
Althof SE, Turner LA, Levine SB, Bodner D, Kursh ED and Resnick MI: Through eyes of
women: Sexual and psychological responses of women to their partner's treatment with
self-injection or external vacuum therapy. J. Urol., 147:1024-1027, 1992.
61.
Bodner DR, Leffler E and Frost F: The Role of Intracorporal Injection of Vasoactive
Medications for Restoration of Erection in the SCI Male - A Three-Year Follow-up.
Paraplegia, 30(2): 118-120, 1992.
62.
Bodner DR and Resnick MI: Operations for Renal Stones. In: Fowler, JE, Jr. (ed.):
Mastery of Surgery. Urologic Surgery, Boston, Little Brown and Company, 1992,
pp. 52-61.
63.
Bodner DR: Sexual Aspects and Rehabilitation in Spinal Cord Injury. In: Stoudemire, A
and Fogel, BS (eds). Principles of Medical Psychiatry, Oxford University Press, 1993,
pp 851-862
64.
Smith EM, Bodner DR, Ruff RC, Hampel N and Resnick MI: Spinal cord compression
secondary to prostate carcinoma: Treatment and prognosis. J. Urol, 149:330-333,
1993.
65.
Pretlow TG, Wolman SR, Micale MA, Pelly RJ, Kursh ED, Resnick MI, Bodner DR,
Jacobberger JW, Delmoro EM, et al: Xenografts of Primary Human Prostatic
Carcinoma. J Nat’l. Cancer Inst. 85(5): 394-8, 1993.
66.
Shingleton WB and Bodner DR: The development of urologic complications in
relationship to bladder pressures in spinal cord injury patients -- Journal of the American
Paraplegia Society, 16 (1): 14 -17, 1993.
67.
Smith EM and Bodner DR: Sexual Dysfunction After Spinal Cord Injury. In: Bodner,
DR (ed): Urologic Clinics of North America, Vol. 20, 1993: pp. 535-542.
BIBLIOGRAPHY (continued)
68.
Bodner, DR (ed.): Urologic Clinics of North America: Spinal Cord Injury, Vol. 20 (3),
1993.
69.
Wainstein MA, He F, Robinson D, Kung HJ, Schwartz S, Giaconia JM, Edgehouse NL,
Prtlow TP, Bodner DR, Kursh ED, et al.: Androgen-Dependent Xenograft Model Derived
from a Primary Human Prostatic Carcinoma. Cancer Res. 1994 Dec. 1:54(23): 6049-52.
70.
Creasey GH, and Bodner DR: A Review and Current Concepts of Sacral Stimulation,
Journal Neurorehabilitation, 1995.
71.
Bodner DR: Neurogenic Bladder, In: Urology Secrets. Resnick MI & Novick AC (ed.)
Philadelphia, Hanley & Belfus, Inc., 44-46, 1995.
72.
Bodner DR: Radionuclide Studies, In: Urology Secrets. Resnick MI & Novick AC (ed.) Philadelphia, Hanley & Belfus, Inc., 20-21, 1995.
73.
Bodner DR: Scrotal Abscess. In: Urology Secrets. Resnick MI & Novick AC (ed.) Philadelphia, Hanley, & Belfus, Inc., 215-216, 1995.
74.
Sandock DS, Gothe BG, and Bodner DR: Trimethoprim-Sulfamethaxazole Prophylaxis
Against Urinary Tract Infection in the Chronic Spinal Cord Injury Patient. Paraplegia:
33, 156-160, 1995.
75.
Bodner DR, Selzman AA, and Spirnak JP: Evaluation and Treatment of Bladder
Rupture. Seminars in Urology. Vol. 8 (No. 1), 62-65, 1995.
76.
Carlin BI, Bodner DR, Spirnak JP, and Resnick MI: Role of Finasteride in the Treatment
of Recurrent Hematuria Secondary to Benign Prostatic Hyperplasia. Prostate 31:3 (May
15, 1997), 180-182.
77.
Seftel AD, Reigle M, Bodner DR: Neurorehabilitation and Sexual Function After Spinal
Cord Injury. In: Lazar, RB (ed): Principles of Neurologic Rehabilitation, New York,
McGraw Hill, 1998, Chapter 25, p. 433-444.
78.
Haas CA, Bodner DR, Hampel N. and Resnick MI: Systemic candidiasis Presenting with
Prostatic Abscess. Br J Urol, 82(3): 450-451, 1998.
79.
Brown SL, Haas CA, Koehler M, Bodner DR and Seftel AD: Hepatotoxicity related to
Intracavernous pharmacoltherapy with papaverine. Urology, 52:844-847, 1998.
80.
Perkash I, Linsenmeyer TA, Bodner DR, Anderson RU: Detrusor-sphincter dyssynergia
and vesico urethral reflux: management. Spinal Cord. 1998 Jan; 36(1):2-5.
81.
Bodner DR: Urologic Management of Acute Spinal Cord Injury. AUA News -1999
82.
Bodner DR, Haas CA, Krueger B, Seftel AD: Intraurethral Alprostadil for Treatment of
Erectile Dysfunction in Spinal Cord Injury Patients. Urology - 53(1): 199-202, 1999.
BIBLIOGRAPHY (continued)
83.
Bodner DR, Greenberg DB, Seftel AD: Sexual Aspects and Rehabilitation in Spinal Cord
Injury. In: Stoudemire A and Fogel BS (eds): Psychiatric Care of the Medical Patient 2nd
Edition, Oxford University Press, New York 1000, pp. 1081-94.
84.
Bodner DR and Levy: Radionuclide Studies, In: Resnick MI and Novick AC, (eds):
Urology Secrets Second Edition. Philadelphia. Hanley and Belfus, Inc. 1999, p22-23.
85.
Bodner DR: Neurogenic bladder. In Resnick MI and Novick AC (eds): Urology
Secrets Second Edition. Philadelphia. Hanley and Belfus, Inc. 1999, p50-51
86.
Bodner DR: Scrotal Abscess. In Resnick MI and Novick AC (eds): Urology Secrets
Second Edition. Philadelphia. Hanley and Belfus, Inc. 1999, p246-247
87
Oefelein MG, Ricchuiti V, Conrad W, Seftel A, Bodner D, Goldman H, Resnick M:
Skeletal fracture associatd with androgen suppression induced osteoporosis: the clinical
incidence and risk factors for patients with prostate cancer. J Urol. 2001.
Nov. 166(5): 1724-8.
88. Bodner DR, McKenna KE, Sipski ML. Restoring sexual function by electrical activation
of the nervous system: a symposium. J Spinal Cord Med. 2001 Fall; 24(3):147.
89.
Oefelein MG, Ricchuiti V, Conrad W, Goldman H, Bodner D, Resnick MI, Seftel A:
Clinical predictors of androgen-independent prostate cancer and survival in the prostatespecific antigen ERA. Urology 60(1): 120-124,2002.
90.
Bodner DR and Perkash I: Urologic Management in Spinal Cord Injury. In: Lin VW (ed)
Bod: Spinal Cord Medicine Principles and Practice-New York, Demos, pp. 299-305,
2003.
91.
Bodner DR: Radionuclide Studies, In: Resnick MI and Novick AC (eds.) Urologic
Secrets-Third Edition-Philadelphia, Hanley and Belfus, Inc-2005
92.
Bodner DR: Neurogenic Bladder, In: Resnick and Novick AC (eds): Urology Secrets
Third Edition-Philadelphia, Hanley and Belfus, Inc. 2005
93.
Bodner DR: Scrotal Abscess. In Resnick MI and Novick AC (eds) Urology Secrets Third
Edition – Philadelphia, Hanley and Belfus, Inc. 2005
94.
Fleshman RL, Wasman JK, Bodner DR, Young RH, MacLennan GT> Mesodermal
adenosarcoma of the testis. Am J Surg Pathol. 2005 Mar;29(3):420-23.
95.
Gustafson KJ, Zelkovic PF, Feng AH, Daper CE, Bodner DR, Grill WM: Fascicular
anatomy and surgical access of the human pudendal nerve. World J Urol. 2005
Dec;23(6):411-9.
96.
Bodner DR: Septic Shock. In: Resnick MI, Elder JS & Spirnak JP (eds): Critical
Decisions in Urology, 3rd Edition. Hamilton London. BC Decker, Inc. 2004, p84-85.
BIBLIOGRAPHY (continued)
97.
Vourganti S, Agarwal PK. Bodner DR, Dogra VS. Ultrasonographic Evaluation of Renal
Infections: Radiol Clin North Am 2006 Nov;44(6):763-75.
98.
Consortium for Spinal Cord Medicine. Bladder Management for Adults with Spinal Cord
Injury. A clinical practice guideline for healthcare providers. JSCM. 2006; 29: pg 527573
99.
Bodner DR: Peer review of scientific papers. JSCM. 2006;29(2):91.
100.
Sipski M, Alexander M, Bodner D, Brackett N, Elliot S, Jackson AB, Sonksen J:
Development of International Standards to document to sexual and reproductive function
after spinal cord injury: preliminary report JRRD: 2007;44:1:83-90
101.
Ellis RJ, Zhou EH, Fu P, Kaminsky DA, Sodee DB, Faulhaber PF, Bodner D,
Resnick MI. Single photon emission eomputerized tomography with capromab pendetide
plus computerized tomography image set co-registration independently predicts
biochemical failure. J Urol. 2008 May; 179(5):1768-73.
102.
Zhou EH, Ellis RJ, Cherullo E, Colussi V, Xu F, Chen WD, Gupta S, Whalen CC,
Bodner D, Resnick MI, Rimm AA, Koroukian SM. Radiotherapy and survival in prostate
cancer patients: a population-based study. Int J Radiat Oncol Biol Phys. 2009 Jan 1;
73(1): 15-23.
103.
Alexander MS, Biering_Sorensen F, Bodner D, Brackett NL, Cardenas D,
Charlifue S, Creasey G, Dietz V, Ditunno J, Donovan W, Elliott SL, Estores I, Graves
DE, Green B, Gousse A, Jackson AB, Kennelly M, Karlsson AK, Krassioukov A, Krogh
K, Linsenmeyer T, Marino R, Mathias CJ, Perkash I, Sheel AW, Schilero G, Schurch B,
Sonksen J, Stiens S, Wecht J, Wuermser LA, Wyndaele JJ. International standards to
document remaining autonomic function after spinal cord injury. Spinal Cord. 2009 Jan;
47(1):36-43.
104.
Bodner DR: Veteran’s day reflections. J Spinal Cord Med. 2008; 31(5)485.
105.
Vykhovanets EV, Shukla S, MacLennan GT, Vykovanets OV, Bodner DR, Gupta
S. 11-1 beta-induced post-transition effect of NF-kappaB provides time-dependent wave
of signals for initial phase of intraprostatic inflammation. Prostate. 2009 May 1;
69(6):633-43.
106.
Bodner DR: The Bors Award: legacy of Ernest H. J. “Pappy” Bors, MD. J Spinal
Cord Med. 2009;32(1): 1-2.
107.
Bodner DR: Expanding the options of spinal cord injury research. J Spinal Cord
Med. 2009. 32(2):103
108.
Bodner DR: A pioneer in optimism: the legacy of Donald Munro, MD. J Spinal
Cord Med. 2009. 32(4):355-6.
109.
Bodner DR: The Comarr Memorial Award for Distinguished Clinical Service: the
legacy of A. Estin Comarr, MD. J Spinal Cord Med. 2009; 32(3):213-4.
110.
Alexander MS, Brackett NL, Bodner D, Elliott S, Jackson A, Sonksen J.
Measurement of sexual functioning after spinal cord injury: preferred instruments. J
Spinal Cord Med. 2009;32(3):226-36.
111.
Singh M, Perkash and Bodner DR: Urologic Management in Spinal Cord
Injury. In: Lin
W (ed) Spinal Cord Medicine Principles and Practice Second Edition-New York DemosIn Press